First published · Last updated
Hesperidin Enhances the Antitumor Effect of Gefitinib Against Non-Small Cell Lung Cancer via Activation of Endoplasmic Reticulum Stress
A journal article published by IMR Press reports that combining hesperidin with gefitinib increases antitumor activity against non-small cell lung cancer through activation of endoplasmic reticulum stress. The supplied source metadata includes only the publisher and content type without further study details.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 5/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
The paper describes a potential therapeutic enhancement for non-small cell lung cancer treatment.

